Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Bibliographic Details
Main Authors: Xueting Wan, Mengyao Song, Aiyun Wang, Yang Zhao, Zhonghong Wei, Yin Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.887775/full
_version_ 1818061309344743424
author Xueting Wan
Xueting Wan
Mengyao Song
Mengyao Song
Aiyun Wang
Aiyun Wang
Aiyun Wang
Yang Zhao
Yang Zhao
Yang Zhao
Zhonghong Wei
Zhonghong Wei
Yin Lu
Yin Lu
Yin Lu
author_facet Xueting Wan
Xueting Wan
Mengyao Song
Mengyao Song
Aiyun Wang
Aiyun Wang
Aiyun Wang
Yang Zhao
Yang Zhao
Yang Zhao
Zhonghong Wei
Zhonghong Wei
Yin Lu
Yin Lu
Yin Lu
author_sort Xueting Wan
collection DOAJ
first_indexed 2024-12-10T13:46:16Z
format Article
id doaj.art-7382f3f15a554ae2bb932dbd9f70e529
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-10T13:46:16Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-7382f3f15a554ae2bb932dbd9f70e5292022-12-22T01:46:26ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-04-011310.3389/fimmu.2022.887775887775Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis TherapyXueting Wan0Xueting Wan1Mengyao Song2Mengyao Song3Aiyun Wang4Aiyun Wang5Aiyun Wang6Yang Zhao7Yang Zhao8Yang Zhao9Zhonghong Wei10Zhonghong Wei11Yin Lu12Yin Lu13Yin Lu14Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing, ChinaJiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing, ChinaDepartment of Biochemistry and Molecular Biology, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing, ChinaJiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2022.887775/fullmicrobiomeimmunotherapyimmune checkpointangiogenesisprebioticsChinese medicine
spellingShingle Xueting Wan
Xueting Wan
Mengyao Song
Mengyao Song
Aiyun Wang
Aiyun Wang
Aiyun Wang
Yang Zhao
Yang Zhao
Yang Zhao
Zhonghong Wei
Zhonghong Wei
Yin Lu
Yin Lu
Yin Lu
Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy
Frontiers in Immunology
microbiome
immunotherapy
immune checkpoint
angiogenesis
prebiotics
Chinese medicine
title Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy
title_full Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy
title_fullStr Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy
title_full_unstemmed Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy
title_short Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy
title_sort corrigendum microbiome crosstalk in immunotherapy and anti angiogenesis therapy
topic microbiome
immunotherapy
immune checkpoint
angiogenesis
prebiotics
Chinese medicine
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.887775/full
work_keys_str_mv AT xuetingwan corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT xuetingwan corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT mengyaosong corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT mengyaosong corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT aiyunwang corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT aiyunwang corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT aiyunwang corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT yangzhao corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT yangzhao corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT yangzhao corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT zhonghongwei corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT zhonghongwei corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT yinlu corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT yinlu corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy
AT yinlu corrigendummicrobiomecrosstalkinimmunotherapyandantiangiogenesistherapy